{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:11:49Z","timestamp":1781604709334,"version":"3.54.5"},"reference-count":71,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.vaccine.2007.02.084","type":"journal-article","created":{"date-parts":[[2007,3,23]],"date-time":"2007-03-23T06:49:18Z","timestamp":1174632558000},"page":"4213-4222","source":"Crossref","is-referenced-by-count":30,"title":["Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies"],"prefix":"10.1016","volume":"25","author":[{"given":"Jacqueline","family":"Weyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Mans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit J.","family":"Viljoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis H.","family":"Nel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.02.084_bib1","series-title":"Virus taxonomy: the classification and nomenclature of viruses. The 8th report of the International Committee on Taxonomy of Viruses","first-page":"623","article-title":"Lyssaviruses","author":"Tordo","year":"2005"},{"key":"10.1016\/j.vaccine.2007.02.084_bib2","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1056\/NEJMoa050382","article-title":"Survival after treatment of rabies with induction of coma","volume":"352","author":"Willoughby","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.02.084_bib3","unstructured":"Anonymous. World Survey for Rabies No 35 for the year 1999. WHO\/CD\/CSR\/EPH\/2002.10. World Health Organization, Geneva, 2002."},{"key":"10.1016\/j.vaccine.2007.02.084_bib4","unstructured":"Anonymous. World Health Organization Expert Consultation on Rabies: First report. World Health Organization Technical report series 931. World Health Organization, Geneva, 2005, pp. 15\u201319."},{"key":"10.1016\/j.vaccine.2007.02.084_bib5","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1056\/NEJMcp042140","article-title":"Prophylaxis against rabies","volume":"351","author":"Rupprecht","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.02.084_bib6","series-title":"The Natural History of Rabies","first-page":"477","article-title":"Rabies control of terrestrial wildlife by population reduction","author":"Debbie","year":"1991"},{"key":"10.1016\/j.vaccine.2007.02.084_bib7","unstructured":"Anonymous. Field application of oral rabies vaccines for dogs: report of a WHO consultation organized in collaboration with the Office International des Epizooties (OIE). World Health Organization, Geneva, 1998; WHO\/EMC\/ZDI\/98, 15."},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.084_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.virusres.2005.03.017","article-title":"Oral vaccination of dogs with recombinant rabies virus vaccines","volume":"111","author":"Rupprecht","year":"2005","journal-title":"Vir Res"},{"key":"10.1016\/j.vaccine.2007.02.084_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/312163a0","article-title":"Expression of rabies virus glycoprotein from a recombinant vaccinia virus","volume":"312","author":"Kieny","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2007.02.084_bib10","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1073\/pnas.81.22.7194","article-title":"Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein recombinant virus vaccine","volume":"81","author":"Wiktor","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.02.084_bib11","series-title":"Rabies","first-page":"335","article-title":"Development of a vaccinia-rabies glycoprotein recombinant virus vaccine","author":"Rupprecht","year":"1988"},{"issue":"12","key":"10.1016\/j.vaccine.2007.02.084_bib12","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.2460\/javma.2005.227.1912","article-title":"Rabies surveillance in the United States during 2004","volume":"227","author":"Krebs","year":"2005","journal-title":"JAVMA"},{"key":"10.1016\/j.vaccine.2007.02.084_bib13","first-page":"459","article-title":"SAG-2 oral rabies vaccine","volume":"60","author":"Schumacher","year":"1993","journal-title":"OJVR"},{"issue":"11","key":"10.1016\/j.vaccine.2007.02.084_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM198703123161106","article-title":"Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease","volume":"316","author":"Redfield","year":"1987","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2007.02.084_bib15","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1056\/NEJMoa010560","article-title":"Human infection due to recombinant vaccinia-rabies glycoprotein virus","volume":"345","author":"Rupprecht","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.02.084_bib16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/302490a0","article-title":"Infectious vaccinia virus recombinants that express hepatitis B surface antigen","volume":"302","author":"Smith","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2007.02.084_bib17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.2992092","article-title":"Recombinant vaccinia virus: immunization against multiple pathogens","volume":"229","author":"Perkus","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2007.02.084_bib18","series-title":"Recombinant poxviruses","first-page":"207","article-title":"Immunogenicity and antigen presentation","author":"Andrew","year":"1992"},{"key":"10.1016\/j.vaccine.2007.02.084_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/viro.2000.0792","article-title":"A striking property of recombinant poxviruses: efficient inducers of in vivo expansion of primed CD8+ T cells","volume":"280","author":"Zavala","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2007.02.084_bib20","first-page":"343","article-title":"Poxviruses as vaccine vectors. Comparative Immunology","volume":"26","author":"Pastoret","year":"2003","journal-title":"Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2007.02.084_bib21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.virol.2005.09.020","article-title":"Replication-defective viruses as vaccines and vaccine vectors","volume":"344","author":"Dudek","year":"2006","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.vaccine.2007.02.084_bib22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.7589\/0090-3558-27.4.681","article-title":"Oral vaccination of skunks with raccoon poxvirus recombinants expressing the rabies glycoprotein or the nucleoprotein","volume":"27","author":"Fekadu","year":"1991","journal-title":"J Wild Dis"},{"issue":"12\u201313","key":"10.1016\/j.vaccine.2007.02.084_bib23","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/S0264-410X(97)00062-5","article-title":"Raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine","volume":"15","author":"Hu","year":"1997","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2007.02.084_bib24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0264-410X(95)00171-V","article-title":"Human safety and immunogenicity of a canarypox\u2013rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system","volume":"14","author":"Fries","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.084_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/1568005033481123","article-title":"Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery","volume":"3","author":"Sutter","year":"2003","journal-title":"Curr Drug Targets\u2013Infect Disord"},{"key":"10.1016\/j.vaccine.2007.02.084_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.copbio.2004.09.001","article-title":"Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?","volume":"15","author":"Drexler","year":"2004","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.vaccine.2007.02.084_bib27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0264-410X(02)00403-6","article-title":"Lack of toxicity and persistence in the mouse associated with administration of candidate DNA and modified vaccinia virus Ankara (MVA)-based HIV vaccine for Kenya","volume":"21","author":"Hanke","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.084_bib28","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0264-410X(02)00771-5","article-title":"Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteer","volume":"21","author":"Moorthy","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.084_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1128\/JVI.77.1.179-190.2003","article-title":"Immunization of newborn rhesus macaques with simian immunodefiency virus (SIV) vaccine prolongs survival after oral challenge with virulent SIVmac251","volume":"77","author":"Van Rompay","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.02.084_bib30","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1016\/S0264-410X(01)00075-5","article-title":"Osterhaus ADME. Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques","volume":"19","author":"Stittelaar","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.084_bib31","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72","author":"Meyer","year":"1991","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2007.02.084_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1998.9123","article-title":"The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses","volume":"244","author":"Antoine","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2007.02.084_bib33","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","article-title":"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine","volume":"79","author":"Blanchard","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2007.02.084_bib34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/viro.1998.9397","article-title":"Marker rescue of the host range restriction defects of modified vaccinia virus Ankara","volume":"251","author":"Wyatt","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2007.02.084_bib35","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.02.084_bib36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.1997.8845","article-title":"Host range and cytopathogenicity of highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line","volume":"238","author":"Carroll","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2007.02.084_bib37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1099\/0022-1317-79-2-347","article-title":"Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells","volume":"49","author":"Drexler","year":"1998","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.084_bib38","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/JVI.74.2.923-933.2000","article-title":"Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine","volume":"74","author":"Ram\u03afrez","year":"2000","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.084_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0163-7258(98)00039-4","article-title":"Cancer vaccines: novel approaches and new promise","volume":"81","author":"Minev","year":"1999","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.vaccine.2007.02.084_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0165-2478(00)00244-3","article-title":"Recombinant viruses as a tool for therapeutic vaccination against human cancers","volume":"74","author":"Bonnet","year":"2000","journal-title":"Immunol Lett"},{"issue":"4","key":"10.1016\/j.vaccine.2007.02.084_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0264-410X(96)00195-8","article-title":"Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model","volume":"15","author":"Carroll","year":"1997","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2007.02.084_bib42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0264-410X(97)00226-0","article-title":"Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime\/MVA boost vaccination regime","volume":"16","author":"Hanke","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.084_bib43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0264-410X(01)00389-9","volume":"20","author":"Gomez","year":"2002","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.02.084_bib44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nm0498-397","article-title":"Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara","volume":"4","author":"Schneider","year":"1998","journal-title":"Nat Med"},{"issue":"21","key":"10.1016\/j.vaccine.2007.02.084_bib45","doi-asserted-by":"crossref","first-page":"11859","DOI":"10.1128\/JVI.77.21.11859-11866.2003","article-title":"Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia virus Ankara expressing a CD8+ T cell epitope derived from the circumsporozoite protein of Plasmodium yeoli","volume":"77","author":"Gonz\u00e1lez-Aseguinolaza","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.02.084_bib46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0264-410X(99)00278-9","article-title":"Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models","volume":"18","author":"D\u00e9gano","year":"2000","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.02.084_bib47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0167-5699(00)01612-1","article-title":"The prime-boost strategy: exciting prospects for improved vaccination","volume":"21","author":"Ramshaw","year":"2000","journal-title":"Immunol Today"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.084_bib48","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.it.2003.11.009","article-title":"Jump-start the immune system: prime-boosting comes of age","volume":"25","author":"Woodland","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2007.02.084_bib49","series-title":"The culture of animal cells: a manual of basic technique","author":"Freshney","year":"1994"},{"issue":"10","key":"10.1016\/j.vaccine.2007.02.084_bib50","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/BF02796323","article-title":"Establishment and characterization of chicken embryo fibroblast clone LSCC-H32","volume":"18","author":"Kaaden","year":"1982","journal-title":"In Vitro"},{"key":"10.1016\/j.vaccine.2007.02.084_bib51","unstructured":"Sambrook J, Russell DW. Molecular cloning: a laboratory manual, 3rd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, pp. 1.31\u20131.38."},{"issue":"4","key":"10.1016\/j.vaccine.2007.02.084_bib52","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2144\/03344bm02","article-title":"Improved host range selection for recombinant modified vaccinia virus Ankara","volume":"34","author":"Staib","year":"2003","journal-title":"Biotechniques"},{"key":"10.1016\/j.vaccine.2007.02.084_bib53","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2144\/00286st04","article-title":"Transient host range selection for genetic engineering of modified vaccinia virus Ankara","volume":"28","author":"Staib","year":"2000","journal-title":"Biotechniques"},{"issue":"23","key":"10.1016\/j.vaccine.2007.02.084_bib54","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.vaccine.2004.10.006","article-title":"Immune responses to recombinants of South African vaccine strain of lumpy skin disease generated by using thymidine kinase gene insertion","volume":"23","author":"Wallace","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.084_bib55","unstructured":"Weyer J. Immune responses to recombinant poxviruses expressing lyssavirus glycoprotein genes. University of Pretoria, Ph.D. thesis, 2006, p. 88."},{"key":"10.1016\/j.vaccine.2007.02.084_bib56","unstructured":"Moss B, Earl PL. Expression of proteins in mammalian cells using vaccinia viral vectors. In: Current Protocols in Molecular Biology. John Wiley and Sons, p. 16.15.1\u201316.15.5."},{"key":"10.1016\/j.vaccine.2007.02.084_bib57","doi-asserted-by":"crossref","unstructured":"Byrd CM, Hruby DE. Construction of recombinant vaccinia virus. in: Isaacs, SN., (Ed.), Vaccinia virus and poxvirology, Humana Press, Totowa New Jersey, p31\u201340.","DOI":"10.1385\/1-59259-789-0:031"},{"key":"10.1016\/j.vaccine.2007.02.084_bib58","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0166-0934(81)90036-7","article-title":"The preparation of orthopoxvirus DNA","volume":"2","author":"Esposito","year":"1981","journal-title":"J Virol Meth"},{"key":"10.1016\/j.vaccine.2007.02.084_bib59","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0166-0934(91)90129-N","article-title":"Direct identification of recombinant virus plaques by PCR","volume":"35","author":"Pasamontes","year":"1991","journal-title":"J Virol Meth"},{"key":"10.1016\/j.vaccine.2007.02.084_bib60","series-title":"Laboratory techniques in rabies","first-page":"88","article-title":"The fluorescent antibody test","author":"Dean","year":"1996"},{"issue":"4","key":"10.1016\/j.vaccine.2007.02.084_bib61","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.vaccine.2005.08.003","article-title":"One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies","volume":"24","author":"Lodmell","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.084_bib62","series-title":"Laboratory techniques in Rabies","first-page":"181","article-title":"A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus-neutralizing antibody","author":"Smith","year":"1996"},{"issue":"3","key":"10.1016\/j.vaccine.2007.02.084_bib63","first-page":"108","article-title":"Transient dominant selection of recombinant vaccinia viruses","volume":"64","author":"Falkner","year":"1990","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.02.084_bib64","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1128\/JVI.74.9.4236-4243.2000","article-title":"Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies","volume":"74","author":"Stittelaar","year":"2000","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.02.084_bib65","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.4049\/jimmunol.172.6.3745","article-title":"Control of simian\/human immunodeficiency virus viremia and disease progression after Il-2-augmented DNA-Modified Vaccinia virus Ankara nasal vaccination in nonhuman primates","volume":"172","author":"Bertley","year":"2004","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2007.02.084_bib66","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1128\/JVI.78.8.3930-3940.2004","article-title":"Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol","volume":"78","author":"Ramsburg","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.02.084_bib67","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.vaccine.2003.10.010","article-title":"Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology","volume":"22","author":"De Waal","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.084_bib68","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1128\/JVI.70.9.6418-6424.1996","article-title":"Oral immunization with a replication deficient recombinant vaccinia virus protects mice against influenza","volume":"70","author":"Bender","year":"1996","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.02.084_bib69","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1099\/vir.0.81181-0","article-title":"Recombinant poxviruses as mucosal vaccine vectors","volume":"86","author":"Gherardi","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2007.02.084_bib70","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1073\/pnas.96.8.4512","article-title":"Mucosal vaccination overcomes barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity","volume":"96","author":"Belyakov","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.02.084_bib71","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1016\/j.vaccine.2004.02.039","volume":"22","author":"Lodmell","year":"2004","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07002824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07002824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T22:07:06Z","timestamp":1587420426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07002824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":71,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0264410X07002824"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.02.084","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}